Crohn's Disease and Colitis Trial, Not Yet Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Phase A (active disease group):
- You are 18 years old or older
- You have been diagnosed with ulcerative colitis (UC) for at least 3 months
- Your UC is currently moderately to severely active, based on a standard scoring system
- Your doctor has recommended starting a targeted treatment for your UC, but you have not begun it yet
- If you are taking steroid tablets (like prednisone), your dose has been stable for at least 3 weeks and is no higher than 20 mg per day
- You are scheduled for a colonoscopy to check your disease activity as part of your normal care
- You are able to follow all the study procedures
- Your Body Mass Index (BMI) is below 23
Phase B (remission group):
- You are 18 years old or older
- You have been diagnosed with UC and your disease is currently in remission (well controlled) while on a targeted therapy
- You are able to follow all the study procedures
- Your BMI is below 23
Who may not be able to join:
- You have been diagnosed with a different type of colitis, such as Crohn's, microscopic, ischemic, infectious, or radiation-related colitis
- You have a medical reason why a colonoscopy would not be safe for you, or you had serious complications during a previous colonoscopy
- You have a bleeding disorder
- You need surgery for your UC
- You do not have the legal capacity to give consent for yourself
- You have used rectal treatments (enemas or suppositories) within the 2 weeks before the study starts
- You have been taking more than 20 mg of prednisone within the 3 weeks before the study starts
- You have low levels of haemoglobin (a measure of anaemia) at the start of the study
- You are pregnant or breastfeeding
- You have an implanted contraceptive device (such as a coil/IUD)
- Your BMI is above 23
- You have been diagnosed with cancer, especially bowel or rectal cancer
- You have a type of osteoporosis involving very rapid bone loss (confirm with trial site)
- You have metal fragments in your body
- You have joint replacements (prostheses)
- You have varicose veins
- You have a condition involving inflamed veins (phlebitis or thrombophlebitis)
- You have a pacemaker fitted
- You have a serious condition affecting blood flow in the arteries (obliterating arteriopathy) (confirm with trial site)
- You are currently menstruating at the time of the study procedure
- You have cancerous tissue or are near an area being treated for cancer
- You have tuberculosis
- You are a child or adolescent still in a growth phase
- You are unable to communicate or describe feelings of pain
- The study doctor considers you unsuitable to participate for any other reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Alessandro Armuzzi, MD, Istituto Clinico Humanitas
Phone: 02 8224 2488
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Efficiency of LIPUS in terms of target-specific extracellular vesicle release
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.